A new systematic review suggests robotic exoskeletons can significantly improve walking, balance, and mobility in children with cerebral palsy, though key questions about long-term effects and adult use remain.
Cerebral palsy is a childhood-onset disability affecting approximately 50 million people worldwide, impacting movement, muscle control, and sometimes causing epilepsy or visual impairment.
A new systematic review published in Disability and Rehabilitation Journal examined the effects of wearable overground robotic exoskeletons for people with cerebral palsy.
Key Findings
The review included 21 studies with 241 participants (average age 9 years). Robotic exoskeleton-assisted therapy showed statistically significant improvements over conventional therapy in four key areas:
- Walking speed
- Walking endurance
- Balance
- High-level mobility (running, jumping)
No significant differences were found for other outcomes, and data were insufficient for some measures.
Safety and User Experience
Skin irritation was reported in some studies but did not prevent continued use. User experiences were generally positive, though most studies did not evaluate subjective feedback.
Limitations
- Only 7 adults were included; results apply mainly to children.
- Few studies assessed long-term retention of benefits after therapy ended.
- No direct comparison to bodyweight-supported treadmill training was made.
- Results could not be stratified by type/severity of cerebral palsy or age.
Current Status in Australia
- Several exoskeletons have been approved by the Therapeutic Goods Administration.
- Therapy sessions may be funded through the National Disability Insurance Scheme (NDIS), but personal ownership of an exoskeleton is not covered.
- An advisory committee is currently reviewing robot-assisted gait training for NDIS funding decisions.